Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James W Dear

Showing results (31-40 of 140) with videos related to

Pageof 14
Sort By:
Proteomics|November 7, 2012
Urinary exosomes: a reservoir for biomarker discovery and potential mediators of intrarenal signallingJames W Dear, Jonathan M Street, Matthew A Bailey
Clinical Toxicology (Philadelphia, Pa.)|December 16, 2015
New regimens for intravenous acetylcysteine, where are we now?D Nicholas Bateman, James W Dear, Simon H L Thomas
BMJ (Clinical Research Ed.)|June 30, 2016
Guidance on acetylcysteine for paracetamol ingestion needs reviewSimon H L Thomas, D Nicholas Bateman, James W Dear
British Journal of Clinical Pharmacology|June 16, 2015
Target biomarker profile for the clinical management of paracetamol overdoseA D Bastiaan Vliegenthart, Daniel J Antoine, James W Dear
British Journal of Clinical Pharmacology|June 28, 2013
Measurement of renal function in patients with chronic kidney diseaseEuan A Sandilands, Neeraj Dhaun, James W Dear, et al.
Biosensors & Bioelectronics|April 13, 2023
Amplification-free electrochemical biosensor detection of circulating microRNA to identify drug-induced liver injuryAppan Roychoudhury, James W Dear, Maïwenn Kersaudy-Kerhoas, et al.
Molecular Biology Reports|April 20, 2024
Evaluation of capillary miR-122 as a prognostic biomarker of paracetamol-induced liver toxicityMarco Cirronis, Sarah Schneemann, Janice Pettie, et al.
Clinical Toxicology (Philadelphia, Pa.)|December 23, 2021
Comment on Fomepizole as an adjunct in acetylcysteine treated acetaminophen overdose patients: a case seriesD Nicholas Bateman, James W Dear, Michael Eddleston, et al.
British Journal of Pharmacology|October 17, 2022
Small interfering RNA: Discovery, pharmacology and clinical development-An introductory reviewPriyanga Ranasinghe, Melisande L Addison, James W Dear, et al.
Archives of Toxicology|November 6, 2024
The emerging role of alternatively activated macrophages to treat acute liver injuryChris Humphries, Melisande L Addison, James W Dear, et al.
Pageof 14

Showing results (31-40 of 140) with videos related to

Sort By:
Pageof 14
Proteomics|November 7, 2012
Urinary exosomes: a reservoir for biomarker discovery and potential mediators of intrarenal signallingJames W Dear, Jonathan M Street, Matthew A Bailey
Clinical Toxicology (Philadelphia, Pa.)|December 16, 2015
New regimens for intravenous acetylcysteine, where are we now?D Nicholas Bateman, James W Dear, Simon H L Thomas
BMJ (Clinical Research Ed.)|June 30, 2016
Guidance on acetylcysteine for paracetamol ingestion needs reviewSimon H L Thomas, D Nicholas Bateman, James W Dear
British Journal of Clinical Pharmacology|June 16, 2015
Target biomarker profile for the clinical management of paracetamol overdoseA D Bastiaan Vliegenthart, Daniel J Antoine, James W Dear
British Journal of Clinical Pharmacology|June 28, 2013
Measurement of renal function in patients with chronic kidney diseaseEuan A Sandilands, Neeraj Dhaun, James W Dear, et al.
Biosensors & Bioelectronics|April 13, 2023
Amplification-free electrochemical biosensor detection of circulating microRNA to identify drug-induced liver injuryAppan Roychoudhury, James W Dear, Maïwenn Kersaudy-Kerhoas, et al.
Molecular Biology Reports|April 20, 2024
Evaluation of capillary miR-122 as a prognostic biomarker of paracetamol-induced liver toxicityMarco Cirronis, Sarah Schneemann, Janice Pettie, et al.
Clinical Toxicology (Philadelphia, Pa.)|December 23, 2021
Comment on Fomepizole as an adjunct in acetylcysteine treated acetaminophen overdose patients: a case seriesD Nicholas Bateman, James W Dear, Michael Eddleston, et al.
British Journal of Pharmacology|October 17, 2022
Small interfering RNA: Discovery, pharmacology and clinical development-An introductory reviewPriyanga Ranasinghe, Melisande L Addison, James W Dear, et al.
Archives of Toxicology|November 6, 2024
The emerging role of alternatively activated macrophages to treat acute liver injuryChris Humphries, Melisande L Addison, James W Dear, et al.
Pageof 14